231 related articles for article (PubMed ID: 35218578)
21. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
22. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
23. Current clinical topics of Lynch syndrome.
Tanakaya K
Int J Clin Oncol; 2019 Sep; 24(9):1013-1019. PubMed ID: 29744602
[TBL] [Abstract][Full Text] [Related]
24. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
25. Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Holter S; Hall MJ; Hampel H; Jasperson K; Kupfer SS; Larsen Haidle J; Mork ME; Palaniapppan S; Senter L; Stoffel EM; Weissman SM; Yurgelun MB
J Genet Couns; 2022 Jun; 31(3):568-583. PubMed ID: 35001450
[TBL] [Abstract][Full Text] [Related]
26. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM
Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601
[TBL] [Abstract][Full Text] [Related]
27. Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
Lentz SE; Salyer CV; Dontsi M; Armstrong MA; Hoodfar E; Alvarado MM; Avila M; Nguyen NT; Powell CB
Gynecol Oncol; 2020 Jul; 158(1):158-166. PubMed ID: 32386910
[TBL] [Abstract][Full Text] [Related]
28. Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers.
Mascarenhas L; Shanley S; Mitchell G; Spurdle AB; Macrae F; Pachter N; Buchanan DD; Ward RL; Fox S; Duxbury E; Driessen R; Boussioutas A
Asia Pac J Clin Oncol; 2018 Dec; 14(6):417-425. PubMed ID: 30294856
[TBL] [Abstract][Full Text] [Related]
29. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.
Takahashi K; Sato N; Sugawara T; Kato A; Sato T; Shimizu D; Tamura D; Kito M; Makino K; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Terada Y
Gynecol Oncol; 2017 Nov; 147(2):388-395. PubMed ID: 28847642
[TBL] [Abstract][Full Text] [Related]
31. Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.
Rodgers-Fouche L; Arora S; Ricker C; Li D; Farooqi M; Balaguer F; Dominguez-Valentin M; Guillem JG; Kanth P; Liska D; Melson J; Mraz KA; Shirts BH; Vilar E; Katona BW; Hodan R
JCO Precis Oncol; 2023 Sep; 7():e2300440. PubMed ID: 37897815
[TBL] [Abstract][Full Text] [Related]
32. [A family with clustered Lynch syndrome: a case report].
Zhu X; Cai L; Xiao J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1263-1266. PubMed ID: 36073228
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
Carwana H; Hoodfar E; Bergoffen J; Li D
Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
[TBL] [Abstract][Full Text] [Related]
34. Lynch Syndrome Screening of Women with Endometrial Cancer: Feasibility and Outcomes in a Community Program.
Turashvili G; Colgan T; McLachlin M; Lin H; Gharbharan R
J Obstet Gynaecol Can; 2022 Feb; 44(2):142-147. PubMed ID: 34656766
[TBL] [Abstract][Full Text] [Related]
35. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
36. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ
Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306
[TBL] [Abstract][Full Text] [Related]
37. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan NAJ; Blake D; Cabrera-Dandy M; Glaire MA; Evans DG; Crosbie EJ
Syst Rev; 2018 Aug; 7(1):121. PubMed ID: 30115102
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
[TBL] [Abstract][Full Text] [Related]
40. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
